Related Experiment Video
Updated: May 9, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Characterizations of HCV NS5A replication complex inhibitors
Donald R O'Boyle Ii1, Jin-Hua Sun, Peter T Nower
1Bristol-Myers Squibb Research and Development, Department of Virology Discovery, 5 Research Parkway, Wallingford, CT 06492, USA. oboyled@bms.com
Small molecules targeting the hepatitis C virus (HCV) NS5A protein show potent antiviral activity. These compounds bind directly to NS5A, inhibiting viral replication through specific structural interactions.
Area of Science:
- Virology
- Medicinal Chemistry
- Drug Discovery
Background:
- The hepatitis C virus (HCV) NS5A protein is a validated target for antiviral drugs.
- Small molecules are effective in inhibiting HCV replication by targeting NS5A.
Purpose of the Study:
- To characterize potent small molecule inhibitors of HCV replication.
- To elucidate the structural elements of inhibitors that interact with the NS5A protein.
- To understand the mechanism of NS5A inhibition by small molecules.
Main Methods:
- UV-activated cross-linking and affinity isolation to probe inhibitor-NS5A interactions.
- Resistance mapping to assess the functional impact of inhibitor subdomains.
- Characterization of inhibitor stereochemistry and its effect on binding.
Main Results:
- Evidence for direct, high-affinity interaction between inhibitors and the NS5A protein.
- Inhibitor-NS5A interaction is dependent on inhibitor stereochemistry.
- Functional data supports a model of inhibition involving covalent binding across an NS5A dimer interface.
Conclusions:
- Small molecule inhibitors bind directly to the NS5A protein with high affinity.
- Stereochemistry is critical for effective inhibitor-NS5A interaction.
- A model of inhibition involving binding across the NS5A dimer interface explains maximal replication inhibition.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Inhibitors of Bacterial DNA Synthesis
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Viruses with RNA Genomes
Inhibitors of Bacterial Protein Synthesis

